Factors Influencing Treatment Adherence Patients with Tuberculosis: A Sytematic Review
DOI:
https://doi.org/10.37287/ijghr.v8i6.2798Keywords:
digital adherence technology, medication adherence, social support, tuberculosisAbstract
Tuberculosis (TB) remains a major global health challenge, and adherence to anti-tuberculosis treatment is essential for treatment success and prevention of treatment interruption and drug resistance. Adherence is influenced by interacting individual, social, economic, treatment-related, and health-system conditions. This systematic review aimed to identify and synthesize evidence published between 2021 and 2026 regarding factors influencing adherence to TB treatment, with particular attention to socioeconomic, health-system, patient-related, social, stigma-related, and technology-related determinants. A PRISMA-guided systematic review searched PubMed, Scopus, and Web of Science for studies published from January 2021 to August 2026. Of 72 articles identified, 8 eligible quantitative, qualitative, or mixed-methods studies were included to synthesize barriers and facilitators of tuberculosis (TB) treatment adherence using a multidimensional framework. Twenty-four studies were reported as meeting the inclusion criteria, comprising 10 cross-sectional studies, 6 cohort studies, 5 qualitative studies, and 3 randomized trials. Five major domains emerged: socioeconomic factors; health-system factors; patient-related factors; social support and stigma; and technology-based adherence approaches. Reported barriers included poverty, transportation costs, food insecurity, prolonged waiting times, medication stock-outs, poor provider–patient communication, forgetfulness, adverse effects, comorbidities, substance use, and stigma. Family support was repeatedly identified as a facilitator, whereas digital adherence interventions demonstrated heterogeneous effects across settings. TB treatment adherence is multidimensional and requires interventions that address practical access barriers, quality of health services, treatment-related difficulties, social support, and stigma in addition to patient education.
References
World Health Organization. (2024). Global tuberculosis report 2024. World Health Organization.
Lawal, A., et al. (2025). Barriers to and enablers of adherence to the treatment of active drug-sensitive tuberculosis in people living with HIV: A mixed method systematic review. BMC Public Health, 26, 39.
Munro, S., et al. (2007). Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Medicine, 4(7), e238.
World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. World Health Organization.
Naidoo, P., et al. (2021). Poverty and TB adherence in South Africa. AIDS Care.
Kebede, A., et al. (2022). Determinants of TB adherence in Ethiopia. Journal of Infection and Public Health.
Benzekri, N. A., et al. (2023). Nutrition support and TB adherence in Senegal. International Journal of Tuberculosis and Lung Disease.
Maruza, A., et al. (2021). Risk factors for TB default in Brazil. Revista de Saúde Pública.
Gebremariam, B. G., et al. (2021). Barriers to TB adherence in Ethiopia. Pan African Medical Journal.
Elbireer, A. M., et al. (2022). Health facility factors and TB default in Uganda. International Journal of Tuberculosis and Lung Disease.
Iweama, C. N., et al. (2023). Side effects and TB adherence in Nigeria. Patient Preference and Adherence.
Naidoo, P., et al. (2021). Comorbidities and TB adherence. South African Medical Journal.
Sardar, T., et al. (2022). Substance use and TB adherence in India. Journal of Family Medicine and Primary Care.
Ushie, B. A., et al. (2021). Family support and TB adherence in Nigeria. African Journal of Primary Health Care.
Kipp, W., et al. (2023). Stigma and TB adherence in Thailand. International Journal of Tuberculosis and Lung Disease.
Hermans, S. M., et al. (2022). SMS reminders and TB adherence in Uganda. JMIR mHealth and uHealth.
Digital adherence technology to improve medication adherence in tuberculosis patients: A systematic review and meta-analysis. (2025). NPJ Primary Care Respiratory Medicine.
The impact of digital adherence technologies on treatment outcomes in TB. (2025). BMC Infectious Diseases.
Middelkoop, K., et al. (2024). Digital pillboxes and TB adherence. The Lancet Digital Health.
VOT and TB treatment completion: A systematic review. (2025). European Respiratory Journal.
Kayigamba, F. R., et al. (2023). Determinants of TB adherence in Rwanda. PLoS ONE.
Masini, E. O., et al. (2024). HIV status and TB treatment interruption in Kenya. BMC Infectious Diseases.
Souza Damasio, P., et al. (2022). Social aspects and TB/HIV adherence in Brazil. Revista Brasileira de Epidemiologia.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Indonesian Journal of Global Health Research

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.








